ID: ALA2375581

Max Phase: Preclinical

Molecular Formula: C20H31NO3

Molecular Weight: 333.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OC(c1ccc(OCCCN2CCCCC2)cc1)C1CCOCC1

Standard InChI:  InChI=1S/C20H31NO3/c22-20(18-9-15-23-16-10-18)17-5-7-19(8-6-17)24-14-4-13-21-11-2-1-3-12-21/h5-8,18,20,22H,1-4,9-16H2

Standard InChI Key:  AXLOOUKYYRLXMU-UHFFFAOYSA-N

Associated Targets(Human)

Histamine H3 receptor 10389 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Histamine H3 receptor 405 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 333.47Molecular Weight (Monoisotopic): 333.2304AlogP: 3.40#Rotatable Bonds: 7
Polar Surface Area: 41.93Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.26CX LogP: 2.46CX LogD: 0.60
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: -0.84

References

1. Labeeuw O, Levoin N, Poupardin-Olivier O, Calmels T, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M..  (2013)  Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile.,  23  (9): [PMID:23535326] [10.1016/j.bmcl.2013.02.118]

Source